New biomarkers in the risk stratification of patients with suspected acute myocardial infarction

Bret Rogers, L. Kristin Newby

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients.

Original languageEnglish (US)
Pages (from-to)341-347
Number of pages7
JournalCurrent Cardiology Reports
Volume4
Issue number4
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Acute Coronary Syndrome
Biomarkers
Myocardial Infarction
Physicians
Research

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

New biomarkers in the risk stratification of patients with suspected acute myocardial infarction. / Rogers, Bret; Newby, L. Kristin.

In: Current Cardiology Reports, Vol. 4, No. 4, 01.12.2002, p. 341-347.

Research output: Contribution to journalArticle

@article{42f1c3589a3d4b0dabff5e9b72b5a634,
title = "New biomarkers in the risk stratification of patients with suspected acute myocardial infarction",
abstract = "The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients.",
author = "Bret Rogers and Newby, {L. Kristin}",
year = "2002",
month = "12",
day = "1",
doi = "10.1007/s11886-002-0071-z",
language = "English (US)",
volume = "4",
pages = "341--347",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - New biomarkers in the risk stratification of patients with suspected acute myocardial infarction

AU - Rogers, Bret

AU - Newby, L. Kristin

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients.

AB - The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients.

UR - http://www.scopus.com/inward/record.url?scp=0036654498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036654498&partnerID=8YFLogxK

U2 - 10.1007/s11886-002-0071-z

DO - 10.1007/s11886-002-0071-z

M3 - Article

VL - 4

SP - 341

EP - 347

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 4

ER -